These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Responsibility for patient education in drug therapy from the viewpoint of the drug industry]. Lerch C Z Arztl Fortbild (Jena); 1994 Dec; 88(12):1055-60. PubMed ID: 7716982 [No Abstract] [Full Text] [Related]
24. China's deadly drug problem. Cyranoski D Nature; 2007 Apr; 446(7136):598-9. PubMed ID: 17410150 [No Abstract] [Full Text] [Related]
25. [Off-label prescriptions. Drug use outside of established guidelines and treatment standard]. Weissbach L; Boedefeld EA Urologe A; 2003 Mar; 42(3):428-32. PubMed ID: 12723544 [No Abstract] [Full Text] [Related]
26. Off-label pharmaceutical use: balancing information, risks, and benefits. Kozma CM Manag Care Interface; 2004 Jan; 17(1):29-30. PubMed ID: 15035597 [No Abstract] [Full Text] [Related]
27. [Old drugs, new possibilities]. Raknes G Tidsskr Nor Laegeforen; 2008 Jan; 128(1):62-5. PubMed ID: 18183061 [No Abstract] [Full Text] [Related]
28. Medical physicists should not encourage or participate in off-label, non-FDA-approved uses of intravascular brachytherapy devices. Against the proposition. Amols HI Med Phys; 2002 Sep; 29(9):2129-30. PubMed ID: 12349934 [No Abstract] [Full Text] [Related]
29. Medical physicists should not encourage or participate in off-label, non-FDA-approved uses of intravascular brachytherapy devices. For the proposition. Jani SK Med Phys; 2002 Sep; 29(9):2128-9. PubMed ID: 12349933 [No Abstract] [Full Text] [Related]
31. Changes at FDA may speed drug approval process and increase off-label use. Reh M J Natl Cancer Inst; 1998 Jun; 90(11):805-7. PubMed ID: 9625166 [No Abstract] [Full Text] [Related]
32. Indian experts protest against off-label drug use. Sharma DC Lancet; 2004 Apr; 363(9418):1372. PubMed ID: 15112705 [No Abstract] [Full Text] [Related]
33. The rationale for off-label prescriptions. Johns Hopkins Med Lett Health After 50; 2000 May; 12(3):6. PubMed ID: 10798286 [No Abstract] [Full Text] [Related]
34. Off-label prescribing of medications for children. Monestime-Williams N; Dickerson LM; Basco WT J S C Med Assoc; 2007 Jun; 103(5):130-3. PubMed ID: 18333578 [TBL] [Abstract][Full Text] [Related]
35. Off label use--label off use? Boos J Ann Oncol; 2003 Jan; 14(1):1-5. PubMed ID: 12488285 [No Abstract] [Full Text] [Related]
36. [Drug committees should not recommend "off label" prescriptions]. Rane A Lakartidningen; 2006 Apr 12-25; 103(15-16):1219. PubMed ID: 16696203 [No Abstract] [Full Text] [Related]
37. [Off label drugs and pediatric hematology-oncology practices]. Le Guyader N; Pouliquen AL; Benoit G; Leverger G Arch Pediatr; 2006 Sep; 13(9):1267-8. PubMed ID: 16814531 [No Abstract] [Full Text] [Related]
38. [Unlicensed and off label usage of some drugs in obstetric practice]. Bozhinova S; Tsvetkov D Akush Ginekol (Sofiia); 2008; 47(5):43-7. PubMed ID: 19227775 [TBL] [Abstract][Full Text] [Related]
39. Indian Medical Association wants off-label prescribing. Mudur G BMJ; 2004 Apr; 328(7446):974. PubMed ID: 15105310 [No Abstract] [Full Text] [Related]
40. Off-base: limitations on Medicare Part D coverage of off-label prescriptions. Medicare Rights Center Care Manag J; 2008; 9(3):142-8. PubMed ID: 18847098 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]